1. Corneal Graft Rejection After Inactivated SARS-CoV-2 Vaccine: Case Report
- Author
-
Mariana Fernandez, Simão and Sérgio, Kwitko
- Subjects
Graft Rejection ,COVID-19 Vaccines ,SARS-CoV-2 ,Keratomileusis, Laser In Situ ,COVID-19 ,Middle Aged ,Allografts ,Slit Lamp Microscopy ,Dexamethasone ,Ophthalmology ,Vaccines, Inactivated ,Humans ,Female ,Dimethylpolysiloxanes ,Glucocorticoids ,Keratoplasty, Penetrating - Abstract
Our aim was to report the case of endothelial corneal allograft rejection after inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine with an atypical presentation.This was a case report.A 63-year-old woman with previous penetrating keratoplasty and laser in situ keratomileusis presented with clinical signs of endothelial corneal graft rejection 24 hours after CoronaVac (SinoVac Biotech, Beijing/China) vaccine. Slitlamp examination showed corneal edema and interface fluid accumulation. It was partially resolved after treatment with topical corticosteroids and polydimethylsiloxane.Corneal allograft rejection was already reported after another SARS-CoV-2 vaccine. This is the first report in the literature describing a possible association with inactivated SARS-CoV-2 vaccine and corneal allograft rejection, especially with laser in situ keratomileusis interface fluid accumulation presentation. Ophthalmologists should be aware of this potential complication.
- Published
- 2021
- Full Text
- View/download PDF